Rhonda Paz

Rhonda has more than 35 years of leadership experience in clinical research administration. She is a transformational leader specializing in organizational structure and development and reengineering of operations to gain greater efficiency and cost savings. As the Executive Director of Investigator Services for YCCI she provides strategic development and operational oversight to creation and provision of services to support faculty in their research initiatives. Prior to her role at Yale, she was a Principal Research Consultant at Huron Consulting Group running large-scale University based projects, the Managing Director and Co-Founder of Phase Up Research and the Chief Operating Officer of GuideStar Clinical Trials Management. In each of these distinct roles she was responsible for strategic development, implementation and management of service lines and products in support of clinical trials at research sites across the country. Prior to her fifteen years in consulting Rhonda was the Associate Center Director for Scientific Administration of the Louisiana Cancer Research Consortium, a joint effort between Tulane University, Louisiana State University, and Xavier University of Louisiana. In this capacity, she was responsible for establishing a centralized administration to oversee and manage the scientific programs - basic, translational and clinical research core facilities. Rhonda additionally served as the Executive Director of Clinical Research and Compliance Services for two prestigious medical centers (MUSC and USF/Moffitt Cancer Center). Her experience makes her uniquely adept at program development, start-up and re-engineering of research operations in complex health care organizations.

Rhonda holds a PhD in Health Administration, a BA in Business Administration and Management and is a certified professional business coach, success coach and a certified research contract professional Her guidance and comprehensive knowledge base have lead health care organizations in the creation of efficient research infrastructures positioned for growth, compliance and financial stability.